Drugs for People, not for Profit.

On Saturday 29th September 2009 an article appeared in the Guardian one of the UK’s wider read broadsheets entitled ‘Soaring Drugs Bill Threatens to Bankrupt NHS’. The article refers to a report published on the same day by left leaning think-tank Compass, an organization that describes itself as ‘Direction for the Democratic Left’. It reports ... Drugs for People, not for Profit.

Bio-orthopaedics between innovation and health policies

An interview with Alberto Gobbi By Maria Cristina Paganoni “Bio-orthopaedics”, the youngest and most promising offspring of orthopaedics, can be broadly summarized as the attempt to regenerate damaged joint tissue by activating healing processes at the molecular level. In the light of the current resurgent interest, in the national press, for knee injuries and the ... Bio-orthopaedics between innovation and health policies

Deepening The Public Conversation Around Bioethics (part 2)

(An interview with Dr. Thomas Murray – …continues from the previous entry) Ubois:Great, I really wanted to ask you about cognitive enhancement. A friend of mine just came from a global meeting of international engineers, and there were large delegation from two companies, and both delegations were talking about how many people in the company ... Deepening The Public Conversation Around Bioethics (part 2)

Deepening The Public Conversation Around Bioethics (part 1)

An Interview with Dr. Thomas Murray (Thomas Murray is President of The Hastings Center, an independent bioethics research institute founded in 1969 and based in Garrison, NY.) One of the world’s leading institutions in bioethics, the Hastings Center takes an approach characterized by interdisciplinary inquiry, broad public engagement, scenario-based thinking, public service, and engagement with ... Deepening The Public Conversation Around Bioethics (part 1)

Daniel Callahan in FGB

«[…] a change from an infinite to a finite model of medicine would have to embody a different attitude toward human aging and death. Even if it is well understood in daily medical practice that people get old and die, that is by no means the case in the medical research community. In that community ... Daniel Callahan in FGB